Answers are grounded in this paper and cite their sources.
Uterine leiomyosarcoma (uLMS) represents one of the most common sarcoma histotypes, demonstrating an overall dismal prognosis. Previous studies reported uLMS to carry recurrent somatic BRCA2 homozygous deletions, related to significant clinical benefits from the use of PARP inhibitors.
No takes yet. Share an insight, caveat, or question.
Bielo et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: